Siegfried, supported by the Chinese development organisation NETDA, will build an API manufacturing plant in Nantong, China. The facility will meet cGMP standards. Siegfried said the site has space for a second phase, which may include finished dosage form production. The new facility is expected to be on-stream in 2014.
Pharmaceutical Business Review
Monday, 9 July 2012
Siegfried to build API plant in China
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment